| Name | Ashville Apothecary |
|---|---|
| Organization Name | Robert D Mabe Inc. |
| Location | 3400 State Route 752, Ashville, Ohio 43103 |
| Type | Pharmacy |
| Phone | (740) 983-2501 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
In a project under Horizon 2020, researchers from seven European organizations will examine how the vision of visually impaired people can be restored using electrical stimulation of the brain.
New research – by scientists at the University of Chicago, Johns Hopkins School of Medicine and the University of Iowa in the USA – describes a novel COVID-19 vaccine candidate that has achieved impressive immunologic results in mouse studies.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Heart disease and infection are major complications and the leading causes of death in patients with chronic kidney disease. It is now well established that immune system dysfunction is involved in both of these pathological processes.
› Verified 9 days ago
| NPI Number | 1225029457 |
| Organization Name | ROBERT D MABE INC. |
| Doing Business As | ASHVILLE APOTHECARY |
| Type | Pharmacy |
| Address | 3400 State Route 752, Ashville, OH 43103 |
| Phone Number | 740-983-2501 |
News Archive
In a project under Horizon 2020, researchers from seven European organizations will examine how the vision of visually impaired people can be restored using electrical stimulation of the brain.
New research – by scientists at the University of Chicago, Johns Hopkins School of Medicine and the University of Iowa in the USA – describes a novel COVID-19 vaccine candidate that has achieved impressive immunologic results in mouse studies.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Heart disease and infection are major complications and the leading causes of death in patients with chronic kidney disease. It is now well established that immune system dysfunction is involved in both of these pathological processes.
› Verified 9 days ago
News Archive
In a project under Horizon 2020, researchers from seven European organizations will examine how the vision of visually impaired people can be restored using electrical stimulation of the brain.
New research – by scientists at the University of Chicago, Johns Hopkins School of Medicine and the University of Iowa in the USA – describes a novel COVID-19 vaccine candidate that has achieved impressive immunologic results in mouse studies.
A report published this week in the New England Journal of Medicine shows that the 50 percent of metastatic melanoma patients with a specific genetic mutation benefit from the drug Vemurafenib - increasing median survival from about 6 months to 15.9 months. In patients who responded, the drug stopped cancer progression for a median 6.7 months.
Heart disease and infection are major complications and the leading causes of death in patients with chronic kidney disease. It is now well established that immune system dysfunction is involved in both of these pathological processes.
› Verified 9 days ago
Ashville Apothecary Type: Pharmacy Location: 3400 State Route 752, Ashville, Ohio 43103 Phone: (740) 983-2501 |